4.7 Article

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Monocyte Subsets With High Osteoclastogenic Potential and Their Epigenetic Regulation Orchestrated byIRF8

Amitabh Das et al.

Summary: In wild-type mice, Ly6C(hi) and Ly6C(int) monocytes are the primary source of osteoclast formation, with their potential dictated by various factors. In the absence of interferon regulatory factor 8 (IRF8), all three monocyte subsets show higher osteoclastogenic potential. Enhanced NFATc1 nuclear translocation and amplified transcriptomic and epigenetic changes direct increased osteoclastogenesis in IRF8-deficient mice.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Cell & Tissue Engineering

Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy

Katrina M. Lappin et al.

Summary: Bone homeostasis and hematopoiesis are closely linked in the hypoxic bone marrow environment, with erythropoietin playing a key role in regulating erythropoiesis. Recent studies have shed light on the effects of EPO-stimulated erythropoiesis on bone homeostasis, highlighting potential implications for clinical practice. Further research is needed to better understand the role of Epo-Epor signaling in bone maintenance.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen

Meiling Zhu et al.

Summary: CSF1 may play a significant role in mature osteoclasts, with c-fms being crucial in regulating the function of these cells.

PLOS ONE (2021)

Article Endocrinology & Metabolism

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients

Sukanya Suresh et al.

Summary: The study suggests that EPO treatment is an independent risk factor for hip fractures in hemodialysis patients, with higher EPO doses correlating with higher fracture risks. The findings indicate that EPO treatment may have contributed to changing trends in fracture incidence among these patients in recent decades.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Pharmacology & Pharmacy

Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis

Michal Eger et al.

Summary: The study found that a lipophilic super-active derivative of vasoactive intestinal peptide (VIP), namely stearyl-norleucine-VIP (SNV), exhibited superior anti-inflammatory and anti-osteoclastogenic effects compared to VIP.

FRONTIERS IN PHARMACOLOGY (2021)

Article Cell & Tissue Engineering

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss

Martina Rauner et al.

Summary: High levels of erythropoietin (Epo) can be harmful to bone health in adult organisms, and EpoR in osteoprogenitor cells plays a crucial role in regulating osteoblast function and osteoblast-mediated osteoclastogenesis.

BONE RESEARCH (2021)

Article Physiology

Active hematopoiesis triggers exosomal release of PRDX2 that promotes osteoclast formation

Gulzhakhan Sadvakassova et al.

Summary: Increased erythropoiesis secondary to anemia leads to upregulation of PRDX2, which is released in exosomes and acts to induce osteoclast formation. Exosomes play a crucial role in the process of osteoclastogenesis induced by hematopoietic cells.

PHYSIOLOGICAL REPORTS (2021)

Article Endocrinology & Metabolism

High Plasma Erythropoietin Predicts Incident Fractures in Elderly Men with Normal Renal Function: The MrOS Sweden Cohort

Hallgerdur Lind Kristjansdottir et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Erythropoietin-Induced Changes in Bone and Bone Marrow in Mouse Models of Diet-Induced Obesity

Sukanya Suresh et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible

Albert Kolomansky et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cell & Tissue Engineering

Erythropoietin modulates bone marrow stromal cell differentiation

Sukanya Suresh et al.

BONE RESEARCH (2019)

Review Cell Biology

Common signalling pathways in macrophage and osteoclast multinucleation

Marie Pereira et al.

JOURNAL OF CELL SCIENCE (2018)

Article Cell Biology

Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus

Bo Huang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Immunology

Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis

Michal Eger et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Scaling of titanium implants entrains inflammation-induced osteolysis

Michal Eger et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis

Manfred Nairz et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Erythropoietin in bone - Controversies and consensus

Sahar Hiram-Bab et al.

CYTOKINE (2017)

Article Biochemistry & Molecular Biology

Erythropoietin directly stimulates osteoclast precursors and induces bone loss

Sahar Hiram-Bab et al.

FASEB JOURNAL (2015)

Article Pharmacology & Pharmacy

ARA 290 for treatment of small fiber neuropathy in sarcoidosis

Monique van Velzen et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)

Article Endocrinology & Metabolism

3D Assessment of Cortical Bone Porosity and Tissue Mineral Density Using High-Resolution mu CT: Effects of Resolution and Threshold Method

Paolo E. Palacio-Mancheno et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2014)

Review Biochemistry & Molecular Biology

Signalling by the βc family of cytokines

Timothy R. Hercus et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2013)

Article Endocrinology & Metabolism

Negative Regulation of Osteoclast Precursor Differentiation by CD11b and beta 2 Integrin-B-Cell Lymphoma 6 Signaling

Kyung-Hyun Park-Min et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2013)

Article Medicine, Research & Experimental

Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function

Julia F. Charles et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Biochemistry & Molecular Biology

The Receptor That Tames the Innate Immune Response

Michael Brines et al.

MOLECULAR MEDICINE (2012)

Article Pharmacology & Pharmacy

Anemia and Chronic Kidney Disease: Making Sense of the Recent Trials

Vinayak Ramanath et al.

REVIEWS ON RECENT CLINICAL TRIALS (2012)

Article Hematology

Macrophages as novel target cells for erythropoietin

Lilach Lifshitz et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)

Article Multidisciplinary Sciences

Erythropoietin Couples Hematopoiesis with Bone Formation

Yusuke Shiozawa et al.

PLOS ONE (2010)

Article Urology & Nephrology

Past, Present, and Future of Chronic Kidney Disease Anemia Management in the United States

Jay B. Wish

ADVANCES IN CHRONIC KIDNEY DISEASE (2009)

Review Cell Biology

Genetic Control of Bone Formation

Gerard Karsenty et al.

ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)

Article Urology & Nephrology

Normal Bone Anatomy and Physiology

Bart Clarke

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Article Endocrinology & Metabolism

Bone mineral density changes during the menopause transition in a multiethnic cohort of women

Joel S. Finkelstein et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Article Multidisciplinary Sciences

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

Michael Brines et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Biochemistry & Molecular Biology

Skeletal remodeling in health and disease

Mone Zaidi

NATURE MEDICINE (2007)

Article Cardiac & Cardiovascular Systems

Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice

Makoto Nakano et al.

CIRCULATION RESEARCH (2007)

Article Pathology

Osteoclasts: What do they do and how do they do it?

Steven L. Teitelbaum

AMERICAN JOURNAL OF PATHOLOGY (2007)

Review Immunology

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

Hiroshi Takayanagi

NATURE REVIEWS IMMUNOLOGY (2007)

Article Neurosciences

A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery

PT Tsai et al.

JOURNAL OF NEUROSCIENCE (2006)

Article Multidisciplinary Sciences

Derivatives of erythropoietin that are tissue protective but not erythropoietic

M Leist et al.

SCIENCE (2004)

Article Multidisciplinary Sciences

Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

M Brines et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Genetics & Heredity

Genetic regulation of osteoclast development and function

SL Teitelbaum et al.

NATURE REVIEWS GENETICS (2003)

Review Multidisciplinary Sciences

Osteoclast differentiation and activation

WJ Boyle et al.

NATURE (2003)

Review Biochemistry & Molecular Biology

Erythropoietin: Multiple physiological functions and regulation of biosynthesis

R Sasaki et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2000)

Review Multidisciplinary Sciences

Bone resorption by osteoclasts

SL Teitelbaum

SCIENCE (2000)